Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”) announced today that as part of a program to monetize a Standby Letter of Credit (“SBLC”), the Company has received written confirmation that a Ready, Willing and Able (“RWA”) has been issued by HSBC, for delivery by Swift MT 760, of a SBLC. The Company previously entered into an application for the monetizing program whereby the Company is projected to receive gross funding proceeds of approximately $78 million, under the SBLC instrument, on or before June 14, 2024.

Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced the grant of inducement awards of options to purchase a collective total of up to 200,000 shares of common stock. An award was made to one new employee of the Company. The award was granted as an inducement material to the new employee becoming an employee of the Company in accordance with Nasdaq Listing Rule 5635(c)(4) and has been approved by the Company’s Compensation Committee. The inducement award was granted on May 24, 2024. The options have a ten (10) year term and an exercise price of $3.380 ...

First Quarter Fiscal 2025 Total Revenue of $450.6 million, up 22% Year-over-Year Continued Strong Customer Growth with Over 49,200 Customers as of April 30, 2024 MongoDB Atlas Revenue up 32% Year-over-Year; 70% of Total Q1 Revenue  NEW YORK, May 30, 2024 /PRNewswire/ -- MongoDB, Inc. (NASDAQ: MDB) today announced its financial results for the first quarter ended April 30, 2024.

MIAMI, May 29, 2024 /PRNewswire/ -- Innovative Eyewear, Inc. ("Innovative Eyewear" or the "Company") (Nasdaq: LUCY; LUCYW), the developer and seller of smart eyewear, today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules for the issuance and sale of 5,263,161 shares of its common stock at a purchase price per share of $0.475. Additionally, in a concurrent private placement, Innovative Eyewear has also issued unregistered warrants to purchase up to 5,263,161 shares of common stock at an exercise price of $0.475 per share. The unregistered warrants are exercisable immediately upon issuance and will expire ...